Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
25.60
+0.40
+(1.59%)
At close: 8:09:25 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-327,523
-405,970
-500,544
-503,827
-427,336
Investing Cash Flow
228,645
71,186
-1,245,514
541,238
757,288
Financing Cash Flow
-4,511
-5,001
-1,487
-3,876
22,040
End Cash Position
--
--
508,117
2,233,368
2,143,071
Capital Expenditure
-84,388
-19,273
-36,947
-57,879
-91,315
Repayment of Debt
-4,511
-6,771
-8,182
-7,190
-6,247
Free Cash Flow
-411,911
-425,243
-537,491
-561,706
-518,651
12/31/2020 - 5/20/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9PT.F Pliant Therapeutics Inc
2.8600
+0.70%
50BA.SG Bicycle Therapeutics PLC
10.60
-3.64%
AURA Aura Biosciences, Inc.
7.37
-1.86%
TRVI Trevi Therapeutics, Inc.
4.3100
-6.30%
NCNA NuCana plc
1.0200
-6.42%
CNTA Centessa Pharmaceuticals plc
15.66
-5.83%
ADAP Adaptimmune Therapeutics plc
0.5522
-1.30%
VIR Vir Biotechnology, Inc.
9.47
-1.04%
ALNY Alnylam Pharmaceuticals, Inc.
248.94
-0.66%
CADL Candel Therapeutics, Inc.
10.96
-5.76%